期刊文献+

LSS法估算COPD患者茶碱缓释片单用及联用加替沙星时稳态药-时曲线下面积

Area under curve of steady-state concentration of theophylline alone and combined with gatifloxacin in COPD patients by limited sampling strategy
下载PDF
导出
摘要 目的用有限采样法(limited sampling strategy,LSS)估算慢性阻塞性肺疾病(COPD)患者单用茶碱缓释片及联用加替沙星时稳态药-时曲线下面积(AUCs0s^12)。方法测得16名COPD患者口服茶碱缓释片稳态时(单用及联用加替沙星)的血药浓度,以多元线性回归法建立(AUCs0s^12与不同时间点的血药浓度的关联数学模型,并用Jackknife法进行验证。结果单点预测时可以采用给药后2 h或4 h的血药浓度值预报药-时曲线下面积,单用茶碱回归方程为:AUCs0s^12=-3.01+11.15C2(R2=0.97,P<0.05)或AUCs0s^12=-1.34+10.91C4(R2=0.97,P<0.05)。联用加替沙星的回归方程:AUCs0s^12=3.14+10.27C2(R2=0.90,P<0.05)或AUCs0s^12=-9.68+11.74C4(R2=0.96,P<0.05)。二点预测可用给药后2 h及12 h的血药浓度值,单用茶碱回归方程为:AUCs0s^12=-0.28+8.47C2+3.18C12(R2=0.98,P<0.05)。联用加替沙星回归方程为:AUCs0s^12=5.74+3.64C2+8.54C12(R2=0.99,P<0.05)。结论考虑到给药后2 h为药物的达峰时间,推荐单点预测时用给药后2 h的血药浓度值;用2个浓度点进行预测采用给药后2、12 h的血药浓度值。 Objective To estimate steady-state theophylline area under curve (AUC0-12^ss) between 0 and 12 h which was taken alone or combined with gatifloxaein in COPD patients by limited sampling strategy. Methods Sixteen COPD patients were enrolled. The concentration of theophylline was determined after single use at first and then combined with gatifloxaein during the steady-state. Mathematic models to estimate AUC of theophylline correlated with various concentrations were established by multi-linear regression and validated by Jackknife approach. Results Model to predict AUC0-12^ss based on one sampling time (2 or 4 h) was recommended at one sampling point prediction. The regression equation was AUC0-12^ss = --3.01 + 11.15 C2 (R^2 = 0.97, P〈0.05) or AUC0-12^ss = -- 1.34 + 10.91 C4 (R^2 = 0. 97, P〈0. 05) for theophylline taken singly . The regression equation was AUC0-12^ss=3.14+10.27 C2 (R^2 =0.90, P〈 0.05) or AUC0-12^ss=--9.68+11.74 C4 (R^2 =0.96, P〈0.05) for theophylline combined with gatifloxacin. Models based on two sampling time ( 2 and 12 h) predicted accurately when two sampling concentrations were applied. The regression equation was AUC0-12^ss=--0. 28+8.47 C2 +3. 18 C12 (R^2 =0.98, P〈0.05) for theophylline singly taken,and the regression equation was AUC0-12^ss=5.74+3.64 C2 +8.54 C12 (R^2 =0.99, P〈0.05) for theophylline combined with gatifloxacin. Conclusion Considering the peak concentration, C2 is recommended to predict the AUC estimation by one point sampling. C2 and C12 are recommended when applying two point values for prediction.
出处 《中南药学》 CAS 2009年第9期641-644,共4页 Central South Pharmacy
基金 南京军区"122工程"卫生专业学科带头人培养对象研究课题(200898) 镇江市科技计划项目资助(SH2006044)
关键词 茶碱缓释片 有限采样法 加替沙星 Jackknife法 theophylline limited sampling strategy gatifloxacin Jackknife
  • 相关文献

参考文献10

  • 1周裕芬.茶碱类药的临床应用及监测[J].西南民族学院学报(自然科学版),1995,21(1):107-108. 被引量:1
  • 2Borja GC, Loukia T, Kazuhiro I, et al. Theophylline restores histone deacetylase activity and steroid responses in COPD macrophages [J]. The Journal of Experimental Medicine, 2004, 200 ( 5): 689-695.
  • 3丁俊杰,焦正,李中东,施孝金,钟明康.有限采样法估算口服托烷司琼药时曲线下面积模型的建立和验证[J].复旦学报(医学版),2006,33(6):770-775. 被引量:4
  • 4Efron B. Bootstrap methods: another look at the jackknife [J]. Ann statist, 1979, 7 (1): 1-26.
  • 5Sheiner LB, Beal SL. Some suggestions for measuring predictive performance [J]. J pharmacokineti Biopharm, 1981, 9 (4) : 503-504.
  • 6仇向华,梁红云,王渊,芮建中,李金恒.加替沙星对老年慢性阻塞性肺病患者茶碱群体药代动力学的影响[J].医学研究生学报,2008,21(1):43-46. 被引量:8
  • 7梁红云,李承军,陈一芬,耿志林,袁叶.加替沙星对慢性阻塞性肺疾病患者茶碱缓释片体内清除率的影响[J].世界临床药物,2006,27(11):687-689. 被引量:2
  • 8Pawinski T, Kunicki P K, Sobieszczanska M M. et al. A limited sampling strategy for estimating myeophenolic acid area under the curve in adult heart transplant patients treated with concomitant cyclosporine [J]. Journal of Clinical Pharmacy and Therapeutics, 2009, 34 (1): 89-101.
  • 9Mohammadpour A H, Nazemian F, Abtahi B, et al. Estimation of abbreviated mycophenolic acid area under the concentration-time curve during early posttransplant period by limited sampling strategy [J]. Transplantation Proceedings, 2008 , 40 (10): 3668-3672.
  • 10Miura M, Satoh S, Niioka T, et al. Limited sampling strategy for simultaneous estimation of the area under the concentrationtime curve of tacrolimus and mycophenolic acid in adult renal transplant recipients [J]. Therapeutic Drug Monitoring, 2008, 30 (1): 52-59.

二级参考文献31

共引文献11

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部